These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 16041261)
41. Isolated pleural PTLD after cardiac transplantation. Lamba M; Jabi M; Padmore R; Sengar DP; Veinot JP Cardiovasc Pathol; 2002; 11(6):346-50. PubMed ID: 12459436 [TBL] [Abstract][Full Text] [Related]
42. Bone marrow findings of 23 Korean post-transplant lymphoproliferative disorder patients: a single-center experience. Cho MC; Park CJ; Huh J; Chi HS; Jang S; Suh C; Lee KH; Lee JH; Seo JJ; Im HJ Clin Transplant; 2012; 26(4):E381-7. PubMed ID: 22694766 [TBL] [Abstract][Full Text] [Related]
43. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients. Wareham NE; Mocroft A; Sengeløv H; Da Cunha-Bang C; Gustafsson F; Heilmann C; Iversen M; Kirkby NS; Rasmussen A; Sørensen SS; Lundgren JD; J Cancer Res Clin Oncol; 2018 Aug; 144(8):1569-1580. PubMed ID: 29804164 [TBL] [Abstract][Full Text] [Related]
44. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders. Smir BN; Hauke RJ; Bierman PJ; Gross TG; d'Amore F; Anderson JR; Greiner TC Lab Invest; 1996 Oct; 75(4):575-88. PubMed ID: 8874388 [TBL] [Abstract][Full Text] [Related]
45. Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders. Dharnidharka VR; Ruzinova MB; Chen CC; Parameswaran P; O'Gorman H; Goss CW; Gu H; Storch GA; Wylie K Cancer Med; 2019 Mar; 8(3):1013-1023. PubMed ID: 30697958 [TBL] [Abstract][Full Text] [Related]
46. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center]. Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748 [TBL] [Abstract][Full Text] [Related]
47. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children. Wu JF; Ho MC; Ni YH; Chen HL; Lu CY; Hsu HY; Lee PH; Chang MH Transplantation; 2009 Mar; 87(5):758-62. PubMed ID: 19295323 [TBL] [Abstract][Full Text] [Related]
48. Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas. Rinaldi A; Kwee I; Poretti G; Mensah A; Pruneri G; Capello D; Rossi D; Zucca E; Ponzoni M; Catapano C; Tibiletti MG; Paulli M; Gaidano G; Bertoni F Br J Haematol; 2006 Jul; 134(1):27-36. PubMed ID: 16803564 [TBL] [Abstract][Full Text] [Related]
60. Significance of in situ hybridization results for EBV-encoded RNA in post-transplantation lymphoproliferative disorder setting: report from the PTLD.Int Survey. Izadi M; Taheri S Ann Transplant; 2010; 15(4):102-9. PubMed ID: 21183884 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]